OHE's Jorge Mestre-Ferrandiz reviewed the results of OHE's recent study on the R&D cost of developing a new drug at a seminar at University College London. Released in December 2012, the study's purpose was to capture and examine in one place the important research on the cost of drug development that had been published over the past 30 years. Also included was a new analysis of data for the years 1998 through 2002, which produced a cost estimate in line with similar studies.
The UCL presentation is viewable below.
Posted in Drug Development/R&D, Health Technology Assessment, Innovation | Tagged Presentations